ADAMTS1, CDKN2A, CRABP1, MLH1, NR3C1, RUNX3, and SCGB3A1 showed increasing methylation frequencies from adenomas to carcinomas, while HOXA9, MAL, and MGMT displayed overall equal methylation frequencies in all tumor subgroups. This evidence concerns the gene CDKN2A and adenoma.